LYNGSTADAAS BIOMEDICAL CONSULTING AS
Organization
- CEO
- SP
- Chairman of the board
- SP
- Years since formation
- 21 years
- since Dec 21, 2004
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 145,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2024
- 840,200
- NOK
- Annual total result 2024
- 390,231
- NOK
- Total equity 2024
- 2,036,513
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
SP | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
SP | Chairman | 100 % directly |
AØ | Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
SP | Managing Director/CEO, Chairman | 100 % directly |
Last update: May 10, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
SP | Ordinary shares | 145,000 | 100 % |
Shares owned by the LYNGSTADAAS BIOMEDICAL CONSULTING AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 159,754 | 19.57 % | |
| Ordinary shares | 5 | 5 % | |
| NO0012493958 | 4,557 | 3.93 % | |
| NO0010779341 | 10,000 | < 0.01 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 840,200 | 918,281 | 590,770 | 232,765 |
Annual Total Result | 390,231 | 569,172 | -127,240 | 149,027 |
Total assets | 2,325,970 | 2,028,369 | 1,470,816 | 1,525,602 |
Total liabilities | 289,457 | 382,087 | 393,705 | 321,252 |
Total equity | 2,036,513 | 1,646,282 | 1,077,111 | 1,204,350 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 840,200 | 918,281 | 590,770 | 232,765 |
Total operating costs | 451,122 | 322,934 | 723,310 | 83,693 |
Operating result | 389,078 | 595,347 | -132,539 | 149,072 |
Financial income/costs | 1,153 | -26,175 | 5,300 | -45 |
Profit before tax | 390,231 | 569,172 | -127,240 | 149,027 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | 390,231 | 569,172 | -127,240 | 149,027 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 2,108,116 | 1,406,053 | 1,353,264 | 1,337,005 |
Total current assets | 217,854 | 622,316 | 117,551 | 188,597 |
Total assets | 2,325,970 | 2,028,369 | 1,470,816 | 1,525,602 |
Short term debt | 39,457 | 105,907 | 143,705 | 71,252 |
Long term debt | 250,000 | 276,180 | 250,000 | 250,000 |
Total liabilities | 289,457 | 382,087 | 393,705 | 321,252 |
Contributed capital | 145,000 | 145,000 | 145,000 | 145,000 |
Retained earnings | 1,891,513 | 1,501,282 | 932,111 | 1,059,350 |
Total equity | 2,036,513 | 1,646,282 | 1,077,111 | 1,204,350 |
Total equity and liabilities | 2,325,970 | 2,028,369 | 1,470,816 | 1,525,602 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises